Dr. Fatima Al-Hamlan is chair of the global health working group of the Civil Society 20 (C20).
She is a scientist in the Infection and Immunity Department at King Faisal Specialist Hospital and Research Center in Riyadh, as well as an assistant professor at the College of Medicine at Alfaisal University in Riyadh.
Al-Hamlan joined the center as a post-doctorate fellow and global clinical scholar in June 2013, and remained in that position until March 2016. She became a research scientist and head of the Scientific Information Office in April that year.
Al-Hamlan’s focus is on conducting research into women’s health and promoting the health and well-being of Saudi females.
She was a founding member of the Riyadh-based Rofaida Women’s Health Organization in 2016 and is its vice president.
In 2007, Al-Hamlan received a master’s degree in population genetics from Washington State University. Five years later, she obtained a Ph.D. in microbiology, molecular biology and biochemistry from the University of Idaho. She also completed executive education courses at Harvard Business School and Harvard Medical School’s Leadership Program to further develop cross-functional skills, lead organizational change and inspire high-performing teams.
She has received awards for her scientific contributions in her field, including the Princess Nourah University’s Women Pioneers in Health Sciences Research Award in 2018.
Al-Hamlan is currently developing a network to advance women’s health, women in STEMM (Science, Technology, Engineering, Mathematics, and Medicine), and CSOs (Civil Society Organizations) within Saudi Arabia and globally.
